Across TCGA pan-cancer cohorts, SH2D1B Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SH2D1B data layer compared with 24 for mass-spec protein.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SH2D1B Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SH2D1B expression acts as an unfavorable survival marker.

KIRC are the cancer types where SH2D1B Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.244	0.810	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: SH2D1B tumor-vs-normal RNA expression · all SH2D1B data types